Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Status and Prospects of Epigenetics in the Treatment of Lymphoma. | Front Oncol | 2022 | 35463343 | PubTator, text mining | PubMed |
| Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia. | Nat Commun | 2022 | 35459277 | PubTator, text mining | PubMed |
| Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). | Molecules | 2022 | 35458687 | PubTator, text mining | PubMed |
| Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance. | Diagnostics (Basel) | 2022 | 35454017 | PubTator, text mining | PubMed |
| BRD4 Targets the KEAP1-Nrf2-G6PD Axis and Suppresses Redox Metabolism in Small Cell Lung Cancer. | Antioxidants (Basel) | 2022 | 35453346 | PubTator, text mining | PubMed |
| Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing. | Mol Cancer Res | 2022 | 35452513 | PubTator, text mining | PubMed |
| Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic. | Br J Cancer | 2022 | 35444289 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| The paradigm of drug resistance in cancer: an epigenetic perspective. | Biosci Rep | 2022 | 35438143 | PubTator, text mining | PubMed |
| NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity. | Genes Chromosomes Cancer | 2022 | 35430756 | PubTator, text mining | PubMed |
| Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo. | J Clin Invest | 2022 | 35426377 | PubTator, text mining | PubMed |
| Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy. | Pharmacol Res Perspect | 2022 | 35417091 | PubTator, text mining | PubMed |
| Report of the First International Symposium on NUT Carcinoma. | Clin Cancer Res | 2022 | 35417004 | PubTator, text mining | PubMed |
| BRD2 compartmentalizes the accessible genome. | Nat Genet | 2022 | 35410381 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
| Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents. | Molecules | 2022 | 35408693 | PubTator, text mining | PubMed |
| A Nutrient-Based Cellular Model to Characterize Acetylation-Dependent Protein-Protein Interactions. | Front Mol Biosci | 2022 | 35402505 | PubTator, text mining | PubMed |
| MILNP: Plant lncRNA-miRNA Interaction Prediction Based on Improved Linear Neighborhood Similarity and Label Propagation. | Front Plant Sci | 2022 | 35401586 | PubTator, text mining | PubMed |
| A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles. | Front Pharmacol | 2022 | 35401196 | PubTator, text mining | PubMed |
| NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics. | Front Oncol | 2022 | 35372003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=28